SPECIFIC DRUGS FOR A COMPLEX DISEASE - CAN THERE BE A MAGIC BULLET AGAINST RHEUMATOID-ARTHRITIS

被引:2
作者
BARTHEL, HR [1 ]
BURMESTER, GR [1 ]
机构
[1] HUMBOLDT UNIV BERLIN,CHARITE HOSP,DEPT MED 3,D-10098 BERLIN,GERMANY
关键词
D O I
10.1136/ard.54.12.948
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The complexity of RA challenges our search for a better understanding of the interconnected networks. Early treatment will certainly avoid some of the problems presented by the complexity of the disease, and combined treatments seem advantageous for advanced disease. The complexity of overt RA will probably not allow a single agent to exert superior efficacy. Unless a treatable infectious cause is identified, a magic bullet, though theoretically possible, might not exist in reality, in particular if the disease is advanced.
引用
收藏
页码:948 / 950
页数:3
相关论文
共 20 条
[1]   CHARACTERIZATION OF T-CELL RECEPTOR-ALPHA-BETA REPERTOIRE IN SYNOVIAL TISSUE FROM DIFFERENT TEMPORAL PHASES OF RHEUMATOID-ARTHRITIS [J].
BUCHT, A ;
OKSENBERG, JR ;
LINDBLAD, S ;
GRONBERG, A ;
STEINMAN, L ;
KLARESKOG, L .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1992, 35 (02) :159-165
[2]   DOUBLE-BLIND TRIAL OF RECOMBINANT GAMMA-INTERFERON VERSUS PLACEBO IN THE TREATMENT OF RHEUMATOID-ARTHRITIS [J].
CANNON, GW ;
PINCUS, SH ;
EMKEY, RD ;
DENES, A ;
COHEN, SA ;
WOLFE, F ;
SAWAY, PA ;
JAFFER, AM ;
WEAVER, AL ;
COGEN, L ;
SCHINDLER, JD .
ARTHRITIS AND RHEUMATISM, 1989, 32 (08) :964-973
[3]   RANDOMIZED DOUBLE-BLIND COMPARISON OF CHIMERIC MONOCLONAL-ANTIBODY TO TUMOR-NECROSIS-FACTOR-ALPHA (CA2) VERSUS PLACEBO IN RHEUMATOID-ARTHRITIS [J].
ELLIOTT, MJ ;
MAINI, RN ;
FELDMANN, M ;
KALDEN, JR ;
ANTONI, C ;
SMOLEN, JS ;
LEEB, B ;
BREEDVELD, FC ;
MACFARLANE, JD ;
BIJL, H ;
WOODY, JN .
LANCET, 1994, 344 (8930) :1105-1110
[4]  
FAUBES G, 1994, SCIENCE, V256, P886
[5]  
FIRESTEIN GS, 1990, J IMMUNOL, V144, P3347
[6]   THE SHARED EPITOPE HYPOTHESIS - AN APPROACH TO UNDERSTANDING THE MOLECULAR-GENETICS OF SUSCEPTIBILITY TO RHEUMATOID-ARTHRITIS [J].
GREGERSEN, PK ;
SILVER, J ;
WINCHESTER, RJ .
ARTHRITIS AND RHEUMATISM, 1987, 30 (11) :1205-1213
[7]  
HAAGSMA CJ, 1994, BRIT J RHEUMATOL, V33, P1049
[8]   MODULATION OF MONOCYTE ACTIVATION IN PATIENTS WITH RHEUMATOID-ARTHRITIS BY LEUKAPHERESIS THERAPY [J].
HAHN, G ;
STUHLMULLER, B ;
HAIN, N ;
KALDEN, JR ;
PFIZENMAIER, K ;
BURMESTER, GR .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (03) :862-870
[9]  
JACOBS P, 1986, BONE MARROW TRANSPL, V1, P237
[10]  
JORGENSEN C, 1994, CLIN EXP RHEUMATOL, V12, P435